US STOCK

GMED Stock Analysis

US stocks · market data · technical indicators

GLOBUS MEDICAL INC

GMEDUS stocks

Quote delayed 15 min

9/11 下午08:35 updated

$73.56

-0.96-1.29%

Open

$74.01

High

$74.49

Low

$72.84

Volume

149.22萬

GMED price history

-14.41%

Open

85.94

Latest

73.56

High

88.34

Low

73.56

Average

82.10

AI Composite Technical Analysis

Beta

Hold

Formula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)

AI Score60

Score range 0–100; a higher score indicates a stronger buy signal

Market Status

Hold

Current Price$73.56

Target Price$80.916

Change %-1.29%

Institutional

Flat

Foreign Ownership

Flat

Market Heat

Cautious

Fundamentals (US)

P/E Ratio

18.95x

ROE

11.81%

P/B Ratio

2.09x

Dividend Yield

Market Insight

The score sits in neutral territory (60/100). Waiting for a clearer signal may be warranted. The target price implies roughly 10.00% upside.

This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.

Financial snapshot

Yahoo Finance

GMED - Globus Medical, Inc.

EPS

3.91USD

Forward EPS

5.40USD

P/E

18.95x

Forward P/E

13.72x

P/B

2.09x

ROE

11.81%

ROA

8.74%

Operating margin

24.76%

Profit margin

17.03%

Revenue growth

5.90%

Earnings growth

-26.20%

Dividend yield

Financial statements

	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	$789.61M	$759.85M	$826.42M	$769.05M	$745.34M
Gross profit	$548.17M	$525.79M	$565.31M	$516.51M	$496.58M
Operating income	$195.47M	$161.98M	$181.31M	$135.01M	$122.81M
Net income	$151.57M	$124.30M	$140.59M	$118.97M	$202.85M
Basic EPS	1.12	0.92	1.05	0.88	1.50
Diluted EPS	1.10	0.90	1.03	0.88	1.49

Estimates vs actuals

Next earnings

2026-11-05

EPS estimate

1.20

Revenue estimate

$792.26M

Last surprise

+21.91%

Date	Estimate	Actual	Surprise
2026-11-05	1.20	Not reported	—
2026-08-06	1.10	1.34	+21.91%
2026-05-07	0.92	1.12	+21.73%
2026-02-24	1.15	1.28	+10.96%
2025-11-06	0.78	1.18	+51.14%
2025-08-07	0.75	0.86	+14.92%
2025-05-08	0.75	0.68	-9.16%
2025-02-20	0.75	0.84	+12.21%
2024-11-05	0.65	0.83	+28.28%
2024-08-06	0.68	0.75	+10.73%
2024-05-07	0.57	0.72	+26.98%
2024-02-20	0.61	0.60	-1.67%

Institutional holders

Institution	Quarter	Value held	Portfolio weight
VANGUARD GROUP INC	2025-12-31	$921.1M	0.01%
BlackRock Inc.	2024-06-30	$708.2M	0.02%
STATE STREET CORP	2026-06-30	$293.5M	0.01%
Bridgewater Associates, LP	2026-06-30	$27.8M	0.11%
RENAISSANCE TECHNOLOGIES LLC	2026-06-30	$15.6M	0.02%

13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.

Analyst ratings

15 analysts

Mean target

$103.23

Target range

$84.00 – $125.00

Implied upside

39.35%

Strong buy

Buy

Hold

Sell

Strong sell